Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2024 | Prostate-specific antigen (PSA) decline with apalutamide therapy is associated with longer survival and improved outcomes in individuals with metastatic prostate cancer: a plain language summary of the TITAN study | FUTURE ONCOLOGY |